Does Improving Depression Symptoms in Young Adults With Inflammatory Bowel Disease Alter Their Microbiome?

被引:0
作者
Davies, Julie M. [1 ]
Teh, Jing Jie [2 ]
Ewais, Tatjana [3 ,4 ,5 ]
Begun, Jakob [1 ,6 ]
机构
[1] Univ Queensland, Mater Res, 37 Kent St, Woolloongabba, Qld, Australia
[2] Univ Queensland, Frazer Inst, Woolloongabba, Qld, Australia
[3] Mater Adolescent & Young Adult Hlth Clin, South Brisbane, Qld, Australia
[4] Univ Queensland, Sch Med, St Lucia, Qld, Australia
[5] Griffith Univ, Sch Med & Dent, Gold Coast Campus, Southport, Qld, Australia
[6] Mater Hosp Brisbane, Dept Gastroenterol, South Brisbane, Australia
关键词
microbiome; inflammatory bowel disease; depression; anxiety; adolescents and young adults (AYA); GUT MICROBIOTA; ANXIETY; ASSOCIATION; PREVALENCE; RECURRENCE; DRUGS;
D O I
10.1093/ibd/izae121
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Patients with inflammatory bowel diseases (IBDs) are more likely to have depression and anxiety symptoms compared with healthy individuals and those with other chronic illnesses. Previous studies have shown a link between the microbiome composition and depression symptoms; however, many antidepressant medications have antibacterial activity confounding cross-sectional studies of these populations. Therefore, we aimed to determine whether we could detect longitudinal changes in the microbiome of a subset of patients who participated in a previously published mindfulness-based cognitive therapy (MBCT) study to improve depression symptoms in adolescents and young adults with IBD.Methods Stool samples were collected at baseline and 8 weeks (n = 24 participants, 37 total samples, 13 paired samples). During this time, some participants achieved a 50% reduction in their depression symptoms either through MBCT or treatment as usual with their mental health team (responders). The microbiome composition and function of responders were compared with participants who did not improve their depression scores (nonresponders). Depression scores were determined using the depression, anxiety, and stress score (DASS-21), and metagenomic sequencing of stool samples was performed.Results No difference in alpha diversity was found between responders and nonresponders. Beta diversity measures were similarly unchanged. Clinical features including fecal calprotectin, C-reactive protein, and serum IL-6 levels were unchanged.Conclusions In this small longitudinal study, we were not able to detect longitudinal changes in the microbiome associated with improvement in depression scores. Follow-up studies that are sufficiently powered to detect changes in the microbiome are required to confirm our results. In a small cohort of young adults with inflammatory bowel disease and depression symptoms, we observed no significant longitudinal changes in their microbiome following improvement in their depression scores.
引用
收藏
页码:2428 / 2439
页数:12
相关论文
共 64 条
  • [1] Association Between Depressive Symptoms and Incidence of Crohn's Disease and Ulcerative Colitis: Results From the Nurses' Health Study
    Ananthakrishnan, Ashwin N.
    Khalili, Hamed
    Pan, An
    Higuchi, Leslie M.
    de Silva, Punyanganie
    Richter, James M.
    Fuchs, Charles S.
    Chan, Andrew T.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (01) : 57 - 62
  • [2] Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance
    Ayaz, Muhammad
    Subhan, Fazal
    Ahmed, Jawad
    Khan, Arif-ullah
    Ullah, Farhat
    Ullah, Ihsan
    Ali, Gowhar
    Syed, Nawazish-i-Husain
    Hussain, Sajid
    [J]. JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI, 2015, 22
  • [3] Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Barberio, Brigida
    Zamani, Mohammad
    Black, Christopher J.
    Savarino, Edoardo, V
    Ford, Alexander C.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (05): : 359 - 370
  • [4] The role of menaquinones (vitamin K2) in human health
    Beulens, Joline W. J.
    Booth, Sarah L.
    van den Heuvel, Ellen G. H. M.
    Stoecklin, Elisabeth
    Baka, Athanasia
    Vermeer, Cees
    [J]. BRITISH JOURNAL OF NUTRITION, 2013, 110 (08) : 1357 - 1368
  • [5] Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
    Bisgaard, Tania H.
    Allin, Kristine H.
    Keefer, Laurie
    Ananthakrishnan, Ashwin N.
    Jess, Tine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (11) : 717 - 726
  • [6] Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli
    Bohnert, Juergen A.
    Szymaniak-Vits, Magdalena
    Schuster, Sabine
    Kern, Winfried V.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (09) : 2057 - 2060
  • [7] Trimmomatic: a flexible trimmer for Illumina sequence data
    Bolger, Anthony M.
    Lohse, Marc
    Usadel, Bjoern
    [J]. BIOINFORMATICS, 2014, 30 (15) : 2114 - 2120
  • [8] The gut microbiome in social anxiety disorder: evidence of altered composition and function
    Butler, Mary I. I.
    Bastiaanssen, Thomaz F. S.
    Long-Smith, Caitriona
    Morkl, Sabrina
    Berding, Kirsten
    Ritz, Nathaniel L. L.
    Strain, Conall
    Patangia, Dhrati
    Patel, Shriram
    Stanton, Catherine
    O'Mahony, Siobhain M. M.
    Cryan, John F. F.
    Clarke, Gerard
    Dinan, Timothy G. G.
    [J]. TRANSLATIONAL PSYCHIATRY, 2023, 13 (01)
  • [9] Examination of antimicrobial effect of fluoxetine in experimental sepsis model: An in vivo study
    Cakir, Ahsen
    Bozali, Kubra
    Celikten, Mert
    Guler, Eray Metin
    Sahan, Ebru
    Durdu, Bulent
    Sumbul, Bilge
    Kocyigit, Abdurrahim
    [J]. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (01)
  • [10] microbiomeMarker: an R/Bioconductor package for microbiome marker identification and visualization
    Cao, Yang
    Dong, Qingyang
    Wang, Dan
    Zhang, Pengcheng
    Liu, Ying
    Niu, Chao
    [J]. BIOINFORMATICS, 2022, 38 (16) : 4027 - 4029